Meningioma Clinical Trials 2022

Browse 32 Meningioma Medical Studies Across 220 Cities

3 Phase 3 Trial · 423 Meningioma Clinics

Reviewed by Michael Gill, B. Sc.
25 Meningioma Clinical Trials Near Me
Miami, FL
Boston, MA
Philadelphia, PA
Houston, TX
More Trial Locations
An interactive map to display trial locations for Miami Cancer Institute at Baptist Health, Inc, Dana-Farber Cancer Institute, Children's Hospital of Philadelphia, Texas Children's Hospital, and 202 more locations.
Most Popular References for Meningioma Clinical Trials
Frequency
Citation
Top Hospitals for Meningioma Clinical Trials
Location
Active Meningioma Clinical Trials
All Time Trials for Meningioma
First Recorded Meningioma Trial
Trials
Massachusetts General Hospital, Boston, Massachusetts
5
7
2009
Northwestern University, Chicago, Illinois
4
7
2009
Top Treatments for Meningioma Clinical Trials
Treatment Name
Active Meningioma Clinical Trials
All Time Trials for Meningioma
First Recorded Meningioma Trial
Trials
Cabozantinib
1
1
2022
LUTATHERA® (Lutetium Lu 177 dotatate)
1
1
2022
Top Cities for Meningioma Clinical Trials
City
Active Meningioma Clinical Trials
Top Active Site for Meningioma Clinical Trials
Trial List
New York, New York
10
Memorial Sloan Kettering Cancer Center
Most Recent Meningioma Clinical Trials
Phase 3 Meningioma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
6/20/2022
Phase 2 & 3
10/28/2020
Phase 3
Senior Friendly Meningioma Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: August 8th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.